JPRN-UMIN000007958
Recruiting
Phase 2
Intraretinal vessel treatment for central retinal vein occlusion - IVTEC
Intraretinal vessel treatment for central retinal vein occlusion study team0 sites10 target enrollmentMay 15, 2012
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Cetntral Retinal Artery and Vein Occlusion
- Sponsor
- Intraretinal vessel treatment for central retinal vein occlusion study team
- Enrollment
- 10
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Key exclusion criteria included CRVO with neovascularization, any previous treatment for CRVO, intraocular surgery during the previous 3 months, vascular retinopathy arising from other causes, glaucoma with an advanced visual field defect or uncontrolled ocular hypertension (25 mmHg) despite full therapy, and myocardial infarction or stroke during the last 12 months. All the participants provided their written informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Treatment of macular edema due to central retinal vein occlusion with ranibizumab (Lucentis®). - Lucentis in CRVOThis case-series is designed to evaluate the safety and efficacy of intravitreal ranibizumab (Lucentis®) in the treatment of macular edema due to central retinal vein occlusion.MedDRA version: 12.1Level: LLTClassification code 10007972Term: Central retinal vein occlusionMedDRA version: 12.1Level: LLTClassification code 10054467Term: Macular edemaEUCTR2009-017782-30-ATMedizinische Universität Graz, Universitäts-Augenklinik
Active, not recruiting
Phase 1
Re-treatment with intravitreal application of ranibizumab guided by morphological macular changes documented by optical coherence tomography (OCT) in patients with macular edema due to branch retinal vein occlusiomacular edema secondary to branch retinal vein occlusion (BRVO)MedDRA version: 18.1Level: LLTClassification code 10054467Term: Macular edemaSystem Organ Class: 100000004853MedDRA version: 18.1Level: LLTClassification code 10038906Term: Retinal vein branch occlusionSystem Organ Class: 100000004853Therapeutic area: Diseases [C] - Eye Diseases [C11]EUCTR2012-005439-10-DEniversity of Leipzig Ritterstr. 26, 04109 Leipzig18
Completed
Phase 1
Treatment of macular edema secondary to central vein occlusiocentral vein occlusion.Other retinal vascular occlusionsIRCT201011295270N1Banco de Olhos de Sorocaba15
Active, not recruiting
Not Applicable
Treatment of a chorioretinal disease characterized by alterations in the elastic lamina of the Bruch's membrane, and which typically manifest themselves as streaks radial departure from the optic nerveEUCTR2014-000986-30-ITIRCCS Ospedale San Raffaele U.O. Oculistica
Completed
Not Applicable
Combination therapy with intravitreal tissue plasminogen activator and ranibizumab for subfoveal type 2 choroidal neovascularizatioSubfoveal type 2 choroidal neovascularizationJPRN-UMIN000016870agoya City University Graduate School of Medicine20